OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment
Marcel Jaron, Michael Lehky, M Zara, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2087-2087
Open Access | Times Cited: 14
Marcel Jaron, Michael Lehky, M Zara, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2087-2087
Open Access | Times Cited: 14
Showing 14 citing articles:
An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line
Stefan Hirschberg, Fatemeh Ghazaani, Ghada Ben Amor, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1469-1469
Open Access | Times Cited: 7
Stefan Hirschberg, Fatemeh Ghazaani, Ghada Ben Amor, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1469-1469
Open Access | Times Cited: 7
Studying SARS-CoV-2 interactions using phage-displayed receptor binding domain as a model protein
Beatriz Pérez-Massón, Yazmina Quintana-Pérez, Yaima Tundidor, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Beatriz Pérez-Massón, Yazmina Quintana-Pérez, Yaima Tundidor, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Protein Expression Platforms and the Challenges of Viral Antigen Production
Jamie Sookhoo, Zachary Schiffman, Aruna Ambagala, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1344-1344
Open Access | Times Cited: 1
Jamie Sookhoo, Zachary Schiffman, Aruna Ambagala, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1344-1344
Open Access | Times Cited: 1
Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particles
Ghada Elfayres, Ricky Raj Paswan, Laura Sika, et al.
Journal of Virological Methods (2023) Vol. 322, pp. 114835-114835
Open Access | Times Cited: 3
Ghada Elfayres, Ricky Raj Paswan, Laura Sika, et al.
Journal of Virological Methods (2023) Vol. 322, pp. 114835-114835
Open Access | Times Cited: 3
Design and characterization of chimeric Rabies-SARS-CoV-2 virus-like particles for vaccine purposes
Ernesto Garay, Diego Fontana, Javier Villarraza, et al.
Applied Microbiology and Biotechnology (2023) Vol. 107, Iss. 11, pp. 3495-3508
Open Access | Times Cited: 2
Ernesto Garay, Diego Fontana, Javier Villarraza, et al.
Applied Microbiology and Biotechnology (2023) Vol. 107, Iss. 11, pp. 3495-3508
Open Access | Times Cited: 2
Production of norovirus-, rotavirus-, and enterovirus-like particles in insect cells is simplified by plasmid-based expression
Vili Lampinen, Stina Gröhn, Nina Lehmler, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Vili Lampinen, Stina Gröhn, Nina Lehmler, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Diverse Approaches to Express Recombinant Spike Protein: A Comprehensive Review
Jk Nithya Shree, T Premika, S Sharlin, et al.
Protein Expression and Purification (2024) Vol. 223, pp. 106556-106556
Closed Access
Jk Nithya Shree, T Premika, S Sharlin, et al.
Protein Expression and Purification (2024) Vol. 223, pp. 106556-106556
Closed Access
Strengths and limitations of SARS-CoV-2 virus-like particle systems
Rokaia Sultana, Robert V. Stahelin
Virology (2024) Vol. 601, pp. 110285-110285
Open Access
Rokaia Sultana, Robert V. Stahelin
Virology (2024) Vol. 601, pp. 110285-110285
Open Access
Dimming the corona: studying SARS-coronavirus-2 at reduced biocontainment level using replicons and virus-like particles
Grace Neilsen, Asha Maria Mathew, J.M. Castro, et al.
mBio (2024)
Open Access
Grace Neilsen, Asha Maria Mathew, J.M. Castro, et al.
mBio (2024)
Open Access
Automated and virus variant-programmable surrogate test qualitatively compares to the gold standard SARS-CoV-2 neutralization assay
Dina Ali, Maggie L. Bartlett, Christopher D. Heger, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access
Dina Ali, Maggie L. Bartlett, Christopher D. Heger, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access
SARS-CoV-2 Virus-like Particles (VLPs) Specifically Detect Humoral Immune Reactions in an ELISA-Based Platform
Stefan Hirschberg, Hannes Bauer, Julian Kamhieh‐Milz, et al.
Antibodies (2022) Vol. 11, Iss. 4, pp. 76-76
Open Access | Times Cited: 3
Stefan Hirschberg, Hannes Bauer, Julian Kamhieh‐Milz, et al.
Antibodies (2022) Vol. 11, Iss. 4, pp. 76-76
Open Access | Times Cited: 3
Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particles
Ghada Elfayres, Ricky Raj Paswan, Laura Sika, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Ghada Elfayres, Ricky Raj Paswan, Laura Sika, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Pseudotyping Improves the Yield of Functional SARS-CoV-2 Virus-like Particles (VLPs) as Tools for Vaccine and Therapeutic Development
Andrew J. Zak, Trang Hoang, Christine M. Yee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14622-14622
Open Access | Times Cited: 1
Andrew J. Zak, Trang Hoang, Christine M. Yee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14622-14622
Open Access | Times Cited: 1
SARS-CoV-2 Virus-Like Particles (VLPs) specifically detect humoral immune reactions in an ELISA based platform
Stefan Hirschberg, Hannes Bauer, Julian Kamhieh‐Milz, et al.
(2022)
Open Access | Times Cited: 2
Stefan Hirschberg, Hannes Bauer, Julian Kamhieh‐Milz, et al.
(2022)
Open Access | Times Cited: 2
